148 related articles for article (PubMed ID: 37229083)
21. Oncocytic Variant of Medullary Thyroid Carcinoma - A Case Report.
Parampalli Srinivas S; Das J; Monappa V
Iran J Pathol; 2019; 14(1):83-87. PubMed ID: 31531105
[TBL] [Abstract][Full Text] [Related]
22. Hurthle cell tumor of the thyroid gland: report of a rare case and review of literature.
Okere PC; Olusina DB; Enyinnah MO
Niger J Clin Pract; 2014; 17(3):375-7. PubMed ID: 24714021
[TBL] [Abstract][Full Text] [Related]
23. Clinical impact of follicular oncocytic (Hürthle cell) carcinoma in comparison with corresponding classical follicular thyroid carcinoma.
Wenter V; Albert NL; Unterrainer M; Ahmaddy F; Ilhan H; Jellinek A; Knösel T; Bartenstein P; Spitzweg C; Lehner S; Todica A
Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):449-460. PubMed ID: 32683470
[TBL] [Abstract][Full Text] [Related]
24. Hurthle cell neoplasms of thyroid in south-western region of Saudi Arabia.
Al-Shraim MM; Hussein MR; Musalam AO; Al-Ghandi T; Al-Zahramit H; Mahrouz AA; Abu-Eshy SA
West Afr J Med; 2010; 29(6):398-402. PubMed ID: 21465448
[TBL] [Abstract][Full Text] [Related]
25. Can abundant colloid exclude oncocytic (Hürthle cell) carcinoma in thyroid fine needle aspiration? Cytohistological correlation of 127 oncocytic (Hürthle cell) lesions.
Yang GC; Schreiner AM; Sun W
Cytopathology; 2013 Jun; 24(3):185-93. PubMed ID: 22672530
[TBL] [Abstract][Full Text] [Related]
26. Pathologic study and clinical significance of Hürthle cell papillary thyroid carcinoma.
Mai KT; Thomas J; Yazdi HM; Commons AS; Lamba M; Stinson AW
Appl Immunohistochem Mol Morphol; 2004 Dec; 12(4):329-37. PubMed ID: 15536332
[TBL] [Abstract][Full Text] [Related]
27. Overview of the 2022 WHO Classification of Thyroid Neoplasms.
Baloch ZW; Asa SL; Barletta JA; Ghossein RA; Juhlin CC; Jung CK; LiVolsi VA; Papotti MG; Sobrinho-Simões M; Tallini G; Mete O
Endocr Pathol; 2022 Mar; 33(1):27-63. PubMed ID: 35288841
[TBL] [Abstract][Full Text] [Related]
28. The thyroid Hürthle (oncocytic) cell and its associated pathologic conditions: a surgical pathology and cytopathology review.
Montone KT; Baloch ZW; LiVolsi VA
Arch Pathol Lab Med; 2008 Aug; 132(8):1241-50. PubMed ID: 18684023
[TBL] [Abstract][Full Text] [Related]
29. Outcome and molecular characteristics of non-invasive encapsulated follicular variant of papillary thyroid carcinoma with oncocytic features.
Xu B; Reznik E; Tuttle RM; Knauf J; Fagin JA; Katabi N; Dogan S; Aleynick N; Seshan V; Middha S; Enepekides D; Casadei GP; Solaroli E; Tallini G; Ghossein R; Ganly I
Endocrine; 2019 Apr; 64(1):97-108. PubMed ID: 30689169
[TBL] [Abstract][Full Text] [Related]
30. Activating BRAF Mutations Detected in Mixed Hürthle Cell Carcinoma and Multifocal Papillary Carcinoma of the Thyroid Gland: Report of an Unusual Case and Review of the Literature.
Sinno S; Choucair M; Nasrallah M; Wadi L; Jabbour MN; Nassif S
Int J Surg Pathol; 2016 Sep; 24(6):519-24. PubMed ID: 27006301
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
[TBL] [Abstract][Full Text] [Related]
32. An unusual case of hürthle cell carcinoma presenting as metastatic pleural disease 16 years after thyroidectomy.
Bagherzadegan N; Feller-Kopman D; Ernst A; Haerle S; Lunn W
J Bronchology Interv Pulmonol; 2009 Jul; 16(3):204-6. PubMed ID: 23168555
[TBL] [Abstract][Full Text] [Related]
33. Metastatic Hürthle cell carcinoma of the thyroid presenting as ulcerated scrotum nodules.
Shon W; Ferguson SB; Comfere NI
Am J Dermatopathol; 2010 Jun; 32(4):392-4. PubMed ID: 20514683
[TBL] [Abstract][Full Text] [Related]
34. Clinical, Histopathological, and Radiological Profile of Patients Presenting With Thyroid Malignancies Among the Kerala Population.
Girijakumari CP; Koroth A; Abdul Rasheed MF; Ali Usman A; Basheer S; Rasween Kareem M
Cureus; 2024 Mar; 16(3):e56775. PubMed ID: 38650763
[TBL] [Abstract][Full Text] [Related]
35. A Rare Silent Killer: Right Atrial Metastasis of Thyroid Hürthle Cell Carcinoma.
Luo H; Tulpule S; Alam M; Patel R; Sen S; Yousif A
Case Rep Oncol; 2015; 8(2):233-7. PubMed ID: 26078743
[TBL] [Abstract][Full Text] [Related]
36. Follicular or Hürthle cell neoplasm of the thyroid: can clinical factors be used to predict carcinoma and determine extent of thyroidectomy?
McHenry CR; Thomas SR; Slusarczyk SJ; Khiyami A
Surgery; 1999 Oct; 126(4):798-802; discussion 802-4. PubMed ID: 10520931
[TBL] [Abstract][Full Text] [Related]
37. Risk stratification in follicular neoplasm: a cytological assessment using the modified Bethesda classification.
Ustun B; Chhieng D; Van Dyke A; Carling T; Holt E; Udelsman R; Adeniran AJ
Cancer Cytopathol; 2014 Jul; 122(7):536-45. PubMed ID: 24753500
[TBL] [Abstract][Full Text] [Related]
38. Hurthle cell tumours of the thyroid. Personal experience and review of the literature.
Barnabei A; Ferretti E; Baldelli R; Procaccini A; Spriano G; Appetecchia M
Acta Otorhinolaryngol Ital; 2009 Dec; 29(6):305-11. PubMed ID: 20463834
[TBL] [Abstract][Full Text] [Related]
39. Subcutaneous implantation of oncocytic thyroid cell aggregates nine years later from thyroidectomy. A case report.
Famà F; Pino A; Cavallari V; Fadda G; Ieni A; Dionigi G
Int J Surg Case Rep; 2022 Apr; 93():106935. PubMed ID: 35286984
[TBL] [Abstract][Full Text] [Related]
40. Hürthle Cells on Fine-Needle Aspiration Cytology Are Important for Risk Assessment of Focally PET/CT FDG Avid Thyroid Nodules.
Poller DN; Megadmi H; Ward MJA; Trimboli P
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33260994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
